Psychiatry & Neurology Doctors in Watkins Glen, NY Accepting Medicare

3 Psychiatry & Neurology doctors found. Showing 1 - 3

Dr. Anasuya A Raman, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 106 S Perry St Ste 4, Watkins Glen, NY 14891 Phone: 607-535-8282    Fax: 607-535-8284

Savithri A Satti, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 106 S Perry St, Ste 4, Watkins Glen, NY 14891 Phone: 607-535-8282    Fax: 607-535-8284

Mihai Dascalu, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 106 S Perry St, Ste 4, Watkins Glen, NY 14891 Phone: 607-535-8282    Fax: 607-535-8284

News Archive

PET eliminates approximately 50% of unnecessary surgeries in lung cancer patients

New quantitative data suggests that 30 percent of the surgeries performed for non-small cell lung cancer patients in a community-wide clinical study were deemed unnecessary.

Texas Legislature passes bill to halt Gov. Perry's executive order mandating HPV vaccine

The Texas House on Wednesday voted 135-2 to pass ( HB 1098 ) a Senate-approved bill that would prevent mandatory vaccination for middle school girls in the state until 2011, the New York Times reports (Blumenthal, New York Times , 4/26).

EU study analyzes effectiveness of cardiac computed tomography

Scientists from 28 research facilities in 20 European countries are meeting today in Berlin to kick off the collaborative research project DISCHARGE. The purpose of this project is to determine for which patients with chest pain cardiac CT or cardiac catheterization is best suited.

Nigeria safely relaunches accelerated yellow fever vaccination campaigns

While combatting multiple public health challenges, including the COVID-19 pandemic, the Government of Nigeria, with support of the World Health Organization (WHO) and Gavi, the Vaccine Alliance will safely relaunch an accelerated series of mass preventive vaccination campaigns to protect Nigerians against yellow fever (YF).

Preliminary results of Phase 2b clinical trial of AZ-104 announced by Alexza Pharmaceuticals

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced preliminary results from its 366 patient Phase 2b clinical trial of AZ-104 (Staccato(R) loxapine) in patients with migraine headache.

Read more Medical News

› Verified 2 days ago